Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
Cell Reports|June 15, 2025
An integrated proteomic portrait of prostate cancer progressionJichang Zhang, Keith D Rivera, Daniela Bossi, et al.
The Journal of Clinical Investigation|May 17, 2021
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growthMichael D Nyquist, Lisa S Ang, Alexandra Corella, et al.
Cancer Cell|November 23, 2023
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiationChia-Chun Chen, Wendy Tran, Kai Song, et al.
Nature Medicine|November 6, 2007
Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1Heiko Johnen, Shu Lin, Tamara Kuffner, et al.
Cancer Discovery|November 14, 2022
OncoLoop: A Network-Based Precision Cancer Medicine FrameworkAlessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Nature Cell Biology|December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatmentJenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Nature Communications|December 3, 2021
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progressionMarco Bolis, Daniela Bossi, Arianna Vallerga, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Nature Communications|August 13, 2022
Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancerNader Al-Nakouzi, Chris Kedong Wang, Htoo Zarni Oo, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Cell Reports|June 15, 2025
An integrated proteomic portrait of prostate cancer progressionJichang Zhang, Keith D Rivera, Daniela Bossi, et al.
The Journal of Clinical Investigation|May 17, 2021
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growthMichael D Nyquist, Lisa S Ang, Alexandra Corella, et al.
Cancer Cell|November 23, 2023
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiationChia-Chun Chen, Wendy Tran, Kai Song, et al.
Nature Medicine|November 6, 2007
Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1Heiko Johnen, Shu Lin, Tamara Kuffner, et al.
Cancer Discovery|November 14, 2022
OncoLoop: A Network-Based Precision Cancer Medicine FrameworkAlessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Nature Cell Biology|December 4, 2023
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatmentJenna M Giafaglione, Preston D Crowell, Amelie M L Delcourt, et al.
Nature Communications|December 3, 2021
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progressionMarco Bolis, Daniela Bossi, Arianna Vallerga, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Nature Communications|August 13, 2022
Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancerNader Al-Nakouzi, Chris Kedong Wang, Htoo Zarni Oo, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Pageof 23